A Trial Protocol of Precision Medicine for Patients with RAS Wild Metastatic Colorectal Cancer Using Liquid Biopsy (RAS-liquid Study): A Prospective, Multicenter Observational Study

BACKGROUND: Anti-epidermal growth factor receptor (EGFR) therapy has been identified to prolong the survival of metastatic colorectal cancer (mCRC) patients without RAS mutations. However, its efficacy is not always consistent for these patients. Genomic profiles of primary tumors and metastases are...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuda, Akihisa, Yamada, Takeshi, Takahashi, Takao, Hirata, Keiji, Nagasaka, Takeshi, Ishimaru, Kei, Sakamoto, Kazuhiro, Koda, Keiji, Ishikawa, Toshiaki, Ishida, Hideyuki, Matsuda, Kenji, Kuramochi, Hidekazu, Yoshida, Yoichiro, Sonoda, Hiromichi, Yoshida, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Society of Coloproctology 2022
Materias:
Trial Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801244/
https://www.ncbi.nlm.nih.gov/pubmed/35128137
http://dx.doi.org/10.23922/jarc.2021-042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801244/
https://www.ncbi.nlm.nih.gov/pubmed/35128137
http://dx.doi.org/10.23922/jarc.2021-042

Ejemplares similares